A new trial of nilotinib for GIST patients who have shown progression on imatinib and on sunitinib has opened at Fox Chase Cancer Center. All qualified patients will receive nilotinib (no placebo arm). For details LINK HERE.
Last changed: Jul 08 2008 at 6:11 PM
Back
